Provider
QP101-22 Update for New to Market Medical Drugs: Lecanemab and Lifileucel
Program effective Date: Dec 16, 2022
Program effective Date: Dec 16, 2022
Program effective Date: Dec 14, 2022
Program effective Date: Dec 14, 2022
Program effective Date: Dec 14, 2022
Program effective Date: Dec 14, 2022
Program effective Date: Dec 14, 2022
Program effective Date: Dec 14, 2022
Program effective Date: Dec 14, 2022